首页> 外文期刊>AJR: American Journal of Roentgenology : Including Diagnostic Radiology, Radiation Oncology, Nuclear Medicine, Ultrasonography and Related Basic Sciences >Contrast enhancement in cardiovascular MDCT: effect of body weight, height, body surface area, body mass index, and obesity.
【24h】

Contrast enhancement in cardiovascular MDCT: effect of body weight, height, body surface area, body mass index, and obesity.

机译:心血管MDCT的对比增强:体重,身高,体表面积,体重指数和肥胖症的影响。

获取原文
获取原文并翻译 | 示例
       

摘要

OBJECTIVE: The purpose of our study was to evaluate the effect of body weight, height, body surface area (BSA), body mass index (BMI), and obesity on aortic contrast enhancement in cardiac MDCT. MATERIALS AND METHODS: Seventy-three consecutive patients underwent cardiac CT angiography on a 64-MDCT scanner. Seventy-five mL of contrast medium (350 mg I/mL) was injected at 4.5 mL/s, followed by a 40-mL saline flush at 4.5 mL/s. The scanning delay of CT was determined with a bolus tracking technique. Aortic attenuation was measured over the aortic-root lumen. BMI and BSA were calculated from the patient's body weight and height. The patients were divided into low-(BMI < 30) and high-(> or = 30) BMI groups. Associations of aortic attenuation with body weight, height, BMI, and BSA were evaluated with regression analysis and the Student's t test. RESULTS: Strong inverse correlations were seen between aortic attenuation and body weight (r = -0.73), height (r = -0.47), BMI (r = -0.63), and BSA (r = -0.74) (p < 0.001 for all). The regression formula of aortic attenuation versus body weight suggests that 1.0 mL/kg of contrast medium would yield a mean aortic attenuation of 355 H. The mean aortic attenuation was significantly higher in the low-BMI (352.6 +/- 59.1 H) than in the high-BMI (286.2 +/- 55.5 H) group. The regression formula for aortic attenuation on body weight was aortic attenuation = 586-3.1 body weight (p < 0.001) for the low-BMI group and aortic attenuation = 485-1.9 body weight (p < 0.001) for the high-BMI group, suggesting that the amount of contrast medium required with increased body weight is less in the high-BMI group. This group difference was less pronounced for the regression of aortic attenuation on BSA. CONCLUSION: To achieve a consistent contrast enhancement in cardiac CT angiography (CTA), contrast-medium dose should be adjusted with the body weight or the BSA (which accounts for both the body weight and height factors) to provide adjustment of iodine dose over a wide range of body sizes.
机译:目的:本研究的目的是评估体重,身高,体表面积(BSA),体重指数(BMI)和肥胖对心脏MDCT的主动脉造影增强的影响。材料与方法:连续73例患者在64-MDCT扫描仪上接受了心脏CT血管造影。以4.5 mL / s的速度注入75 mL造影剂(350 mg I / mL),然后以4.5 mL / s的速度注入40 mL盐水。 CT的扫描延迟是通过推注跟踪技术确定的。在主动脉根管腔上测量主动脉衰减。根据患者的体重和身高计算出BMI和BSA。将患者分为低(BMI <30)和高(>或= 30)BMI组。主动脉衰减与体重,身高,BMI和BSA的关联通过回归分析和Student t检验进行评估。结果:主动脉衰减与体重(r = -0.73),身高(r = -0.47),BMI(r = -0.63)和BSA(r = -0.74)之间存在强烈的负相关关系(所有p <0.001 )。主动脉衰减相对于体重的回归公式表明,1.0 mL / kg造影剂会产生355 H的平均主动脉衰减。低BMI(352.6 +/- 59.1 H)的平均主动脉衰减显着高于BMI。高BMI(286.2 +/- 55.5 H)组。低BMI组的主动脉衰减的回归公式为主动脉衰减= 586-3.1体重(p <0.001),高BMI组的主动脉衰减= 485-1.9体重(p <0.001),这表明在高BMI组中,随着体重的增加所需的造影剂的量较少。对于BSA上主动脉衰减的消退,该组差异不太明显。结论:为了在心脏CT血管造影(CTA)中获得一致的造影剂增强效果,应根据体重或BSA(兼顾体重和身高因素)调整造影剂剂量,以在整个过程中调整碘剂量。身体尺寸范围广。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号